Early pain detection and management after esophageal metal stent placement in incurable cancer patients: A prospective observational cohort study

 

 Permissions and Reprints

Background and study aims: Studies of esophageal self-expandable metal stents (SEMS) mainly focus on efficacy and recurrent dysphagia. Retrosternal pain has been described in up to 14 % of these patients, however, prospective daily pain assessment has not yet been performed. We conducted a prospective study to evaluate the occurrence and management of pain after esophageal SEMS deployment.

Patients and methods: A total of 65 patients who underwent SEMS placement for incurable malignant esophageal stenosis were included. Patients used a diary to record intensity of pain twice daily for 2 weeks, according to the Numeric Rating Scale (NRS). A pain score ≥ 4 was used to determine whether patients experienced significant pain. If pain occurred, acetaminophen was used and, in cases of ongoing pain, an opiate was prescribed. Dose, duration, and kind of analgesic were noted.

Results: The rate of significant pain increased from 0 % at baseline to 60 % on Day 1 (P < 0.001), followed by 37 % and 25 % on Days 7 and 14, respectively. The rate of analgesics use increased from 20 % at baseline to 78 % on Day 1 (P < 0.001), followed by 72 % and 62 % on Days 7 and 14, respectively. The use of opiates increased from 14 % at baseline to 42 % on Day 1 (P < 0.001). No variables associated with SEMS related pain were found.

Conclusions: Two-thirds of patients experience significant pain after esophageal SEMS insertion and analgesics, including opiates, are frequently required. Patients need to be informed and preventive prescription of analgesia should be considered in order to improve quality of life.

• References

• 1 Ferlay J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917
  CrossrefPubMedGoogle Scholar
• 2 Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37 (Suppl. 08) 4-66
  PubMedGoogle Scholar
• 3 Stein HJ, Siewert JR. Improved prognosis of resected esophageal cancer. World J Surg 2004; 28: 520-525
  PubMedGoogle Scholar
• 4 Homs MY, Eijkenboom WM, Coen VL et al. High dose rate brachytherapy for the palliation of malignant dysphagia. Radiother Oncol 2003; 66: 327-332
  CrossrefPubMedGoogle Scholar
• 5 Didden P, Spaander MC, Bruno MJ et al. Esophageal stents in malignant and benign disorders. Curr Gastroenterol Rep 2013; 15: 319
  CrossrefPubMedGoogle Scholar
• 6 Murray LJ, Din OS, Kumar VS et al. Palliative radiotherapy in patients with esophageal carcinoma: A retrospective review. Pract Radiat Oncol 2012; 2: 257-264
  CrossrefPubMedGoogle Scholar
• 7 Homs MY, Steyerberg EW, Eijkenboom WM et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 2004; 364: 1497-1504
  CrossrefPubMedGoogle Scholar
• 8 Madhusudhan C, Saluja SS, Pal S et al. Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life. Dis Esophagus 2009; 22: 331-336
  CrossrefPubMedGoogle Scholar
• 9 Anton A, Montalar J, Carulla J et al. Pain in clinical oncology: patient satisfaction with management of cancer pain. Eur J Pain 2012; 16: 381-389
  CrossrefPubMedGoogle Scholar
• 10 van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007; 18: 1437-1449
  CrossrefPubMedGoogle Scholar
• 11 Jensen MP. The validity and reliability of pain measures in adults with cancer. J Pain 2003; 4: 2-21
  CrossrefPubMedGoogle Scholar
• 12 Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs 2005; 14: 798-804
  CrossrefPubMedGoogle Scholar
• 13 Paul SM, Zelman DC, Smith M et al. Categorizing the severity of cancer pain: further exploration of the establishment of cutpoints. Pain 2005; 113: 37-44
  CrossrefPubMedGoogle Scholar
• 14 Serlin RC, Mendoza TR, Nakamura Y et al. When is cancer pain mild, moderate or severe?. Grading pain severity by its interference with function. Pain 1995; 61: 277-284
  PubMedGoogle Scholar
• 15 Cohen MZ, Easley MK, Ellis C et al. Cancer pain management and the JCAHO's pain standards: an institutional challenge. J Pain Symptom Manage 2003; 25: 519-527
  CrossrefPubMedGoogle Scholar
• 16 van Boeckel PG, Siersema PD, Sturgess R et al. A new partially covered metal stent for palliation of malignant dysphagia: a prospective follow-up study. Gastrointest Endosc 2010; 72: 1269-1273
  CrossrefPubMedGoogle Scholar
• 17 van Boeckel PG, Repici A, Vleggaar FP et al. A new metal stent with a controlled-release system for palliation of malignant dysphagia: a prospective, multicenter study. Gastrointest Endosc 2010; 71: 455-460
  CrossrefPubMedGoogle Scholar
• 18 Choi SJ, Kim JH, Choi JW et al. Fully covered, retrievable self-expanding metal stents (Niti-S) in palliation of malignant dysphagia: long-term results of a prospective study. Scand J Gastroenterol 2011; 46: 875-880
  CrossrefPubMedGoogle Scholar
• 19 Van Heel NC, Haringsma J, Spaander MC et al. Esophageal stents for the palliation of malignant dysphagia and fistula recurrence after esophagectomy. Gastrointest Endosc 2010; 72: 249-254
  CrossrefPubMedGoogle Scholar
• 20 Van Heel NC, Haringsma J, Spaander MC et al. Esophageal stents for the relief of malignant dysphagia due to extrinsic compression. Endoscopy 2010; 42: 536-540
  Article in Thieme ConnectPubMedGoogle Scholar
• 21 Uitdehaag MJ, Siersema PD, Spaander MC et al. A new fully covered stent with antimigration properties for the palliation of malignant dysphagia: a prospective cohort study. Gastrointest Endosc 2010; 71: 600-605
  CrossrefPubMedGoogle Scholar
• 22 Siersema PD, Hop WC, van Blankenstein M et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 2001; 54: 145-153
  CrossrefPubMedGoogle Scholar
• 23 Verschuur EM, Repici A, Kuipers EJ et al. New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial. Am J Gastroenterol 2008; 103: 304-312
  CrossrefPubMedGoogle Scholar
• 24 Verschuur EM, Kuipers EJ, Siersema PD. Esophageal stents for malignant strictures close to the upper esophageal sphincter. Gastrointest Endosc 2007; 66: 1082-1090
  CrossrefPubMedGoogle Scholar
• 25 Homs MY, Hansen BE, van Blankenstein M et al. Prior radiation and/or chemotherapy has no effect on the outcome of metal stent placement for oesophagogastric carcinoma. Eur J Gastroenterol Hepatol 2004; 16: 163-170
  CrossrefPubMedGoogle Scholar
• 26 Lecleire S, Di Fiore F, Ben-Soussan E et al. Prior chemoradiotherapy is associated with a higher life-threatening complication rate after palliative insertion of metal stents in patients with oesophageal cancer. Aliment Pharmacol Ther 2006; 23: 1693-1702
  CrossrefPubMedGoogle Scholar
• 27 Verschuur EM, Steyerberg EW, Kuipers EJ et al. Effect of stent size on complications and recurrent dysphagia in patients with esophageal or gastric cardia cancer. Gastrointest Endosc 2007; 65: 592-601
  CrossrefPubMedGoogle Scholar
• 28 Morrison LJ, Morrison RS. Palliative care and pain management. Med Clin North Am 2006; 90: 983-1004
  CrossrefPubMedGoogle Scholar
• 29 Hirdes MM, Vleggaar FP, de Beule M et al. In vitro evaluation of the radial and axial force of self-expanding esophageal stents. Endoscopy 2013; 45: 997-1005
  Article in Thieme ConnectPubMedGoogle Scholar
• 30 Hirdes MM, Siersema PD, Vleggaar FP. A new fully covered metal stent for the treatment of benign and malignant dysphagia: a prospective follow-up study. Gastrointest Endosc 2012; 75: 712-718
  CrossrefPubMedGoogle Scholar